Cited by 47Diabetes Management and ResearchIntravenous Infusion Technology and SafetyPancreatic function and diabetes

Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin

Dudde, R., Thomas Vering, Piechotta, G., Hintsche, R.·2006·IEEE Transactions on Information Technology in Biomedicine

Abstract

For a diabetes mellitus patient, tight control of glucose level is essential. Results are reported of an investigation of the suitability of existing wearable continuous insulin infusors controlled and adjusted by a control algorithm using continuous glucose measurements as input to perform the functionality of an artificial pancreas. Special attention was given to the development of a continuous glucose monitor and to evaluate which quality of input data is necessary for the control algorithm. In clinical trials, it was found that for patients in a controlled environment an autonomously regulating control algorithm leads to an improved adjustment of patient glucose values and less overall insulin infusion as compared with the best fixed preprogrammed insulin infusion profiles of standard pump therapy. For the limited number of cases studied here, functionality of the control algorithm could tolerate some delay between the actual glucose values in the patient interstitial fluid and the algorithm input of up to 30 min. A quasicontinuous glucose measurement delivering actual glucose values every 5-10 min seems to be suited to control an artificial pancreas.

Integrity signals

Registry

Crossref · 10.1109/titb.2006.864477

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dudde et al. developed a minimally-invasive wearable closed-loop quasi-continuous drug infusion system that measures blood glucose levels and infuses insulin automatically.

    “For example, Dudde et al. [30] developed a minimally-invasive wearable closed-loop quasi-continuous drug infusion system that measures blood glucose levels and infuses insulin automatically.”
  • The Dudde et al. device has integrated Bluetooth communication capability for displaying and logging data and receiving commands from a personal digital assistant (PDA) device.

    “The device has integrated Bluetooth communication capability for displaying and logging data and receiving commands from a personal digital assistant (PDA) device.”
  • The glucose monitor consists of a novel silicon sensor that continuously measures glucose levels using a microperfusion technique.

    “The glucose monitor consists of a novel silicon sensor that continuously measures glucose levels using a microperfusion technique and continuous infusion of insulin is achieved by a modified advanced insulin pump.”
  • Continuous infusion of insulin in the Dudde et al. system is achieved by a modified advanced insulin pump.

    “The glucose monitor consists of a novel silicon sensor that continuously measures glucose levels using a microperfusion technique and continuous infusion of insulin is achieved by a modified advanced insulin pump.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dudde, R., Vering, T., Piechotta, G., & Hintsche, R.
Affiliations
Fraunhofer Institute for Silicon Technology (DE)
Venue
IEEE Transactions on Information Technology in Biomedicine
Published
2006-04
Volume
10
Issue
2
Pages
395-402
ISSN
  • 1089-7771 (ISSN-L)
  • 1558-0032
OpenAlex
W2152908566
Cited by
47
References
15
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 4 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 4
FWCI
3.10
Type
journal article
Language
en
Open access
closed
Locations
  • IEEE Transactions on Information Technology in Biomedicine (publishedVersion)
  • PubMed (publishedVersion)
  • Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
continuous insulin infusion, artificial pancreas, continuous glucose monitoring, diabetes mellitus, glycemic control, control algorithms, insulin dose reduction
MeSH terms
Algorithms, Ambulatory Care, Artificial Intelligence, Blood Glucose, Diabetes Mellitus, Drug Therapy, Computer-Assisted, Equipment Design, Feedback, Humans, Insulin, Insulin Infusion Systems, Blood Glucose Self-Monitoring, Equipment Failure Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review